Home » Topics » Articles » Insight

Insight
RSS

Other Financings Of Public Biotechnology Companies: November 1999

Dec. 6, 1999

Venture Capital And Corporate Investments In Biotechnology Companies: November 1999

Dec. 6, 1999

IPO Filings Could Be Signal Of `Open Season On Market'

Dec. 6, 1999

Public Financing Of Biotechnology: November 1999

Dec. 6, 1999

Amgen Jostling For Position In Rheumatoid Arthritis Field

Nov. 29, 1999

Clinical Trial Update: October 1999

Nov. 29, 1999

FDA Submissions, Approvals And Other Actions: October 1999

Nov. 29, 1999

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: October 1999

Nov. 29, 1999

Flu Drugs Ready For Battle, Though Aviron's Entry Delayed

Nov. 22, 1999

Biotech - Big Pharma Collaborations: Modified And Terminated Agreements July 1999 - Oct. 1999#

Nov. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...